Molly Fausone is a third-year medical student at the University of Michigan—she's also paralyzed from the chest down. Despite her physical limits, a new device allows her to perform full-body patient exams with limited physical contact, according to a University of Michigan press release.

A real-time look at how mice’s immune systems repair their brain lining, or meninges, after concussion or mild traumatic brain injury (mTBI) is providing insight into how the human brain heals itself in similar situations, the National Institutes of Health reported this week.

Automated breast ultrasound (ABUS) offers improved breast cancer screening for patients with dense breast tissue and could provide specialists with a significant improvement over handheld screening ultrasound. However, some clinicians worry it may take radiologists too long to interpret ABUS exams, making it less than ideal for population-based screening.

A noninvasive imaging biomarker known as 18F fluorocholine PET/CT has been proving its capability in detecting certain cancers for years, but fresh research out of Honolulu suggests it could be especially useful in identifying chronic liver disease.

Imaging providers should still administer gadolinium-based contrast agents (GBCAs) when necessary, according to a recent commentary published in the Journal of the American College of Radiology. However, the authors added, assessing the “necessity, benefits and risks” of each examination and minimizing repeated scans on the same patient is recommended.

A misconfigured security setting on a radiology interface at Middletown Medical, a multi-specialty physicians group in New York, led to a security breach exposing patient data, including radiology images, reports and Social Security numbers, according to HIPPA Journal.

Over the past decade, U.S. residency applications to diagnostic radiology programs have declined. Boston researchers set out to determine what a resident looks for in a radiology program.

Surgery in breast cancer patients may trigger a negative response in the body that allows dormant cancer cells to thrive. However, according to a new study published in Science Translational Medicine, new research suggests taking a non-steroidal anti-inflammatory drug (NSAID) around the time of surgery could help stop such growth in its tracks.